Immunic Inc

NASDAQ:IMUX   3:59:52 PM EDT
5.47
-0.28 (-4.87%)
Earnings Announcements

Immunic, Inc. Reports First Quarter 2022 Financial Results And Provides Corporate Update

Published: 05/10/2022 10:48 GMT
Immunic Inc (IMUX) - Immunic, Inc. Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Current Cash and Cash Equivalents Are Expected to Fund Immunic Into Q3 of 2023.
Q1 Loss per Share $0.74.
Q1 Earnings per Share View $-0.80 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.72

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.73

More details on our Analysts Page.